According to Sheng et al. (2019), the up-regulation of KIF15 in breast cancer led to poor overall survival, indicating that KIF15 could serve as a potential therapeutic target for triple-negative breast cancer. The gene discussed is KIF15; the disease is triple-negative breast carcinoma.